Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The bad seed: Cancer stem cells in tumor development and resistance
Elle Koren, Yaron Fuchs
Drug Resistance Updates (2016) Vol. 28, pp. 1-12
Closed Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Modes of Regulated Cell Death in Cancer
Elle Koren, Yaron Fuchs
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 245-265
Open Access | Times Cited: 296
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p
Lu Wang, Guang Yang, Danfeng Zhao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 196
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 177
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
Zhiyong Yang, Ning Zhao, Jing Cui, et al.
Cellular Oncology (2019) Vol. 43, Iss. 1, pp. 123-136
Open Access | Times Cited: 159
Cancer drug resistance induced by EMT: novel therapeutic strategies
Javier De Las Rivas, Anamaria Brozović, Sivan Izraely, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 7, pp. 2279-2297
Open Access | Times Cited: 149
Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 74
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
Qingmei Ye, Kai Liu, Qun Shen, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 129
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
Thorsten Stiewe, Tali E. Haran
Drug Resistance Updates (2018) Vol. 38, pp. 27-43
Closed Access | Times Cited: 120
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Huangcan Li, Zhuoying Feng, Ming‐Liang He
Theranostics (2020) Vol. 10, Iss. 16, pp. 7053-7069
Open Access | Times Cited: 118
The key roles of cancer stem cell-derived extracellular vesicles
Chaoyue Su, Jianye Zhang, Yosef Yarden, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 97
Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds
Arnatchai Maiuthed, Wipa Chantarawong, Pithi Chanvorachote
Anticancer Research (2018) Vol. 38, Iss. 7, pp. 3797-3809
Open Access | Times Cited: 90
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 61
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Beyond cisplatin: New frontiers in metallodrugs for hard-to-treat triple negative breast cancer
Muhammad Nafees, Muhammad Hanif, Piaoping Yang
Coordination Chemistry Reviews (2023) Vol. 499, pp. 215507-215507
Closed Access | Times Cited: 26
The tumor microenvironment: shaping cancer progression and treatment response
Sharav Desai, Vipul P. Patel, Kunal Bhosle, et al.
Journal of Chemotherapy (2024), pp. 1-30
Closed Access | Times Cited: 15
A matter of life and death: stem cell survival in tissue regeneration and tumour formation
Despina Soteriou, Yaron Fuchs
Nature reviews. Cancer (2018) Vol. 18, Iss. 3, pp. 187-201
Closed Access | Times Cited: 78
Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics
Himadri Patel, Pritish Nilendu, Devashree Jahagirdar, et al.
Cancer Biology & Therapy (2017) Vol. 19, Iss. 1, pp. 3-12
Open Access | Times Cited: 73
Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress
Yi-Chieh Yang, Ming‐Hsien Chien, Hsin-Yi Liu, et al.
Cancer Letters (2018) Vol. 421, pp. 28-40
Closed Access | Times Cited: 66
3D culture technologies of cancer stem cells: promising ex vivo tumor models
Chengye Zhang, Zhaoting Yang, Da-Long Dong, et al.
Journal of Tissue Engineering (2020) Vol. 11
Open Access | Times Cited: 60
Metal complexes against breast cancer stem cells
Yingsi Li, Boxin Liu, Hongdong Shi, et al.
Dalton Transactions (2021) Vol. 50, Iss. 41, pp. 14498-14512
Closed Access | Times Cited: 47
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
Laura Sofia Soares Carvalho, Nélio Gonçalves, Nuno A. Fonseca, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 1, pp. 60-60
Open Access | Times Cited: 43
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 30
PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1
Xuetao Li, Guangliang Chen, Bin Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Circular RNAs and their roles in head and neck cancers
Yang Guo, Jiechao Yang, Qiang Huang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 54
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
Roberto Ruiu, Lidia Tarone, Valeria Rolih, et al.
Progress in molecular biology and translational science (2019), pp. 119-188
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top